March 14, 2016 — Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
March 11, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Blazer Open ...
February 18, 2016 — AtriCure Inc. announced that the first patient was enrolled and treated at PinnacleHealth Hospitals ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 6, 2016 — A new study determined that the Watchman left atrial appendage closure device is more cost-effective ...
December 22, 2015 — In 2015, results from the ITALIC and CvLPRIT trials, along with studies examining lifestyle factors ...
December 17, 2015 — The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
December 8, 2015 — Biotronik announced the first patient enrollments to the B3 clinical trial. The study will evaluate ...
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device ...
November 20, 2015 — Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 11, 2015 — Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new ...
November 3, 2015 — In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse ...
October 28, 2015 — SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab) ...
October 14, 2015 — AtriCure Inc. announced it has entered into a definitive merger agreement under which AtriCure has ...
October 6, 2015 — Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High ...